Cotinga Pharmaceuticals

About:

Cotinga Pharmaceuticals discovers and develops drug therapies for diseases.

Website: https://www.criticaloutcome.com/

Twitter/X: CriticalOutcome

Description:

Critical Outcome Technologies Inc. (COTI) believes that there must be a better way to get safe and effective new drug therapies to people in need on a more timely, cost effective and efficient manner. Their business is disease-specific drug discovery, optimization and pre-clinical development using a specially developed series of computer models. COTI is focused on the discovery and pre-clinical development of small molecules for the treatment of serious diseases for which current therapy is either lacking or ineffective.

Total Funding Amount:

$4.24M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

London, England, United Kingdom

Founded Date:

1999-01-01

Contact Email:

ir(AT)cotingapharma.com

Founders:

Wayne Danter

Number of Employees:

11-50

Last Funding Date:

2017-10-06

IPO Status:

Public

Industries:

© 2025 bioDAO.ai